High levels of GLS1 also indicate poor patient survival in liver hepatocellular carcinoma (LIHC, HR: 1.313, 95% CI: 1.098–1.569, p = 0.003) and uterine corpus endometrial carcinoma (UCEC, HR: 1.349; 95% CI: 1.116–1.630, p = 0.002). The gene discussed is GLS; the disease is uterine corpus endometrial carcinoma.